Skip to main content
Clinical Trials/NCT01414335
NCT01414335CompletedNot Applicable

Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Randomized Completely Masked Trial

Kyberg Vital GmbH2 sites in 1 country145 target enrollmentStarted: October 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
145
Locations
2
Primary Endpoint
outcome of efficacy

Study Overview

Brief Summary

The purpose of this study is to investigate the effectiveness of a dietary supplement with high dosage of amino acids and vitamins in the treatment of acute and chronic infection of pharyngeal area known as common cold. T

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • men and women with at least two episodes of common cold and infection of ear, nose and pharyngeal area.

Exclusion Criteria

  • people with severe infection like pneumonia, patients expecting an in-patient treatment during the trial, pregnant or breast feeding and people not able to understand the procedure of the treatment

Outcomes

Primary Outcomes

outcome of efficacy

Time Frame: 3 month treatment

For each study day,participants recorded in a diary rectal temperature, symptoms of sneezing, blocked nose or streaming eyes, whether they had problems to swollow and whether they had headache or pain in arms or legs.

Secondary Outcomes

  • outcome of efficacy(3 month treatment)

Investigators

Sponsor
Kyberg Vital GmbH
Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials